After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth. 01022024160133
Article Mental and Behavioral Health Exploring the Psychedelics Landscape: Looking Ahead to Funding in 2024 February 20, 2024
Executive Insights Healthcare Services Navigating Asia’s Regulatory Mosaic: Achieving Excellence in Generative AI for Healthcare January 26, 2024
Article Life Sciences & Pharma The SEA Healthcare, Medtech, and Pharma Landscape in 2023 December 7, 2023
Article Life Sciences & Pharma Hospital Priorities in China in 2023: Strategic Implications for Pharma Companies December 7, 2023
Special Report Biotech and Pharmaceuticals Improving the Understanding Acceptance and Use of Oncology–Relevant Endpoints October 31, 2023
Executive Insights Biotech and Pharmaceuticals The Power of Prediction: How Generative AI Can Drive Biopharma Strategy May 30, 2023